Cite
HARVARD Citation
Akagi, K. et al. (2022). Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study. Thoracic cancer. 13 (16), pp. 2404-2409. [Online].